HUNCHEST projects—advancing low-dose CT lung cancer screening in Hungary

Lung cancer, the leading cause of malignancy-related deaths worldwide, demands proactive measures to mitigate its impact. Low-dose computer tomography (LDCT) has emerged as a promising tool for secondary prevention through lung cancer screening (LCS). The HUNCHEST study, inspired by the success of i...

Full description

Bibliographic Details
Published in:Pathology and Oncology Research
Main Authors: Anna Kerpel-Fronius, Krisztina Bogos
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-05-01
Subjects:
Online Access:https://www.por-journal.com/articles/10.3389/pore.2024.1611635/full
_version_ 1850071332014784512
author Anna Kerpel-Fronius
Krisztina Bogos
author_facet Anna Kerpel-Fronius
Krisztina Bogos
author_sort Anna Kerpel-Fronius
collection DOAJ
container_title Pathology and Oncology Research
description Lung cancer, the leading cause of malignancy-related deaths worldwide, demands proactive measures to mitigate its impact. Low-dose computer tomography (LDCT) has emerged as a promising tool for secondary prevention through lung cancer screening (LCS). The HUNCHEST study, inspired by the success of international trials, including the National Lung Cancer Screening Trial and the Dutch NELSON study, embarked on the first LDCT-based LCS program in Hungary. The initiative assessed the screening efficiency, incorporating lung function tests and exploring the interplay between lung cancer and chronic obstructive pulmonary disease (COPD). Building upon this foundation, an implementation trial involving 18 Hungarian centers supported by the Ministry of Human Capacities demonstrated the feasibility of LCS within a multicentric framework. These centers, equipped with radiology capabilities, collaborated with multidisciplinary oncology teams, ensuring optimal patient pathways. However, a critical challenge remained the patient recruitment. To address this, the HUNCHEST 3 project, initiated in 2023, seeks to engage general practitioners (GPs) to reach out to eligible patients within a municipality collective of 60 thousand inhabitants. The project’s ultimate success is contingent upon the willingness of eligible individuals to undergo LDCT scans. In conclusion, the HUNCHEST program represents a crucial step in advancing lung cancer screening in Hungary. With a focus on efficiency, multidisciplinary collaboration, and innovative patient recruitment strategies, it endeavors to contribute to the reduction of lung cancer mortality and serve as a blueprint for potential nationwide LCS programs.
format Article
id doaj-art-ca0d4e5a46b648f6bb39e2b5e76df861
institution Directory of Open Access Journals
issn 1532-2807
language English
publishDate 2024-05-01
publisher Frontiers Media S.A.
record_format Article
spelling doaj-art-ca0d4e5a46b648f6bb39e2b5e76df8612025-08-20T00:17:11ZengFrontiers Media S.A.Pathology and Oncology Research1532-28072024-05-013010.3389/pore.2024.16116351611635HUNCHEST projects—advancing low-dose CT lung cancer screening in HungaryAnna Kerpel-Fronius0Krisztina Bogos1Department of Radiology, National Korányi Institute for Pulmonology, Budapest, HungaryDirector of the National Korányi Institute for Pulmonology, Budapest, HungaryLung cancer, the leading cause of malignancy-related deaths worldwide, demands proactive measures to mitigate its impact. Low-dose computer tomography (LDCT) has emerged as a promising tool for secondary prevention through lung cancer screening (LCS). The HUNCHEST study, inspired by the success of international trials, including the National Lung Cancer Screening Trial and the Dutch NELSON study, embarked on the first LDCT-based LCS program in Hungary. The initiative assessed the screening efficiency, incorporating lung function tests and exploring the interplay between lung cancer and chronic obstructive pulmonary disease (COPD). Building upon this foundation, an implementation trial involving 18 Hungarian centers supported by the Ministry of Human Capacities demonstrated the feasibility of LCS within a multicentric framework. These centers, equipped with radiology capabilities, collaborated with multidisciplinary oncology teams, ensuring optimal patient pathways. However, a critical challenge remained the patient recruitment. To address this, the HUNCHEST 3 project, initiated in 2023, seeks to engage general practitioners (GPs) to reach out to eligible patients within a municipality collective of 60 thousand inhabitants. The project’s ultimate success is contingent upon the willingness of eligible individuals to undergo LDCT scans. In conclusion, the HUNCHEST program represents a crucial step in advancing lung cancer screening in Hungary. With a focus on efficiency, multidisciplinary collaboration, and innovative patient recruitment strategies, it endeavors to contribute to the reduction of lung cancer mortality and serve as a blueprint for potential nationwide LCS programs.https://www.por-journal.com/articles/10.3389/pore.2024.1611635/fulllung cancerscreeningLDCTpulmonary nodulesimplementation
spellingShingle Anna Kerpel-Fronius
Krisztina Bogos
HUNCHEST projects—advancing low-dose CT lung cancer screening in Hungary
lung cancer
screening
LDCT
pulmonary nodules
implementation
title HUNCHEST projects—advancing low-dose CT lung cancer screening in Hungary
title_full HUNCHEST projects—advancing low-dose CT lung cancer screening in Hungary
title_fullStr HUNCHEST projects—advancing low-dose CT lung cancer screening in Hungary
title_full_unstemmed HUNCHEST projects—advancing low-dose CT lung cancer screening in Hungary
title_short HUNCHEST projects—advancing low-dose CT lung cancer screening in Hungary
title_sort hunchest projects advancing low dose ct lung cancer screening in hungary
topic lung cancer
screening
LDCT
pulmonary nodules
implementation
url https://www.por-journal.com/articles/10.3389/pore.2024.1611635/full
work_keys_str_mv AT annakerpelfronius hunchestprojectsadvancinglowdosectlungcancerscreeninginhungary
AT krisztinabogos hunchestprojectsadvancinglowdosectlungcancerscreeninginhungary